Alnylam

Articles

Refugee Action June 20, 2022 Challenging Ourselves to Help Refugees: Supporting Refugees to Become Work-Ready Alnylam has announced a three-year corporate partnership with Refugee Action, a United Kingdom (UK)-based charity dedicated to helping refugees... Read More ›
Hypertension Article May 13, 2022 Hypertension: Charting A New Course to Address a Public Health Challenge Hypertension (high blood pressure) has seen limited medical innovation in recent history and remains a serious public health issue... Read More ›
Alnylam VBNF May 9, 2022 Building a Collaborative Framework for Facilitating Patient Access to Innovative Therapies Alnylam worked with leading European economists and other healthcare experts to develop what we call the Value-Based Negotiation Framework (VBNF) to help... Read More ›
Alnylam 2021 Annual Report April 15, 2022 2021 Annual Report: CEO Yvonne Greenstreet Reflects on an Important Year in the RNAi Revol ... In conjunction with the publishing of Alnylam's 2021 Annual Report, Alnylam's CEO Yvonne Greenstreet reflects on the year that was... Read More ›
Two of Me Living with Porphyria April 2, 2022 The Making of Two of Me: Living with Porphyria Cynthia Lowen, Emmy-nominated filmmaker, talks about the making of Two of Me: Living with Porphyria. Read More ›
Alnylam 2021 Corporate Responsibility Report March 16, 2022 Alnylam Publishes 2021 Corporate Responsibility Report We're committed to taking bold actions that improve the health of humanity. Our 2021 Corporate Responsibility Report provides details on our progress... Read More ›
Alnylam Health Equity RDD Article February 28, 2022 Supporting Health Equity for All Through Leadership, Action and Partnership "Health equity" means that everyone has a fair and just opportunity to live the healthiest life possible, regardless of who they are, where they live or how... Read More ›
Alnylam Norton Exterior Front February 4, 2022 Alnylam Receives Prestigious Massachusetts Economic Impact Award We are pleased and honored to have been named a Gold Team Massachusetts Economic Impact Award winner for 2022 by MassEcon. Read More ›
Alnylam 2022 GEI January 26, 2022 Alnylam Named to Bloomberg's Gender-Equality Index for 2nd Year in a Row Alnylam has been named to Bloomberg's 2022 Gender-Equality Index (GEI) - an important diversity, equity and inclusion benchmark, for the 2nd year in a row. Read More ›
Alnylam 2021 Patient Access Philosophy Report December 21, 2021 Alnylam Publishes 2021 Patient Access Philosophy Report Alnylam has published its 2021 Patient Access Philosophy Report detailing its actions as a company to provide access to its medicines for those who may... Read More ›
Subscribe to Articles